MetaCap

Aclarion (ACON) vs Biodesix (BDSX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Biodesix is the larger company by market cap ($83.8 million vs $3.5 million), about 23.8 times the size, while Aclarion is growing revenue faster (+65.6% vs +24.1%). Biodesix converts more of its revenue into profit, with a net margin of -39.8% versus -9551.9%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ACON-47.98%BDSX-71.39%
+4%-36%-75%
Oct 7, 20261 yearNov 20, 2026
ACON-47.76%BDSX-70.95%
+4%-35%-74%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ACON versus BDSX key metrics
MetricACONBDSX
Share price$1.22$7.56
Market cap$3.52M$83.83M
1-day change-13.92%-8.92%
YTD return—+11.18%
1-year return—+10.69%
5-year return—-94.38%
EPS (TTM)$-5.01$-2.69
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$75.73K$88.50M
Revenue growth (YoY)+65.62%+24.08%
Net income (latest FY)$-7.23M$-35.27M
Gross margin9.02%—
Operating margin-9312.55%-31.50%
Net margin-9551.87%-39.85%
52-week high$9.36$31.97
52-week low$1.22$5.26
Distance from 52-week high-86.94%-76.35%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+524.18%+347.49%
Average volume34.73K164.58K
Shares outstanding2.88M11.09M
Employees10334
SectorHealth CareHealth Care
IndustryMedical SpecialitiesMedical Specialities

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Biodesix is about 23.8 times larger than Aclarion by market value ($83.83M vs $3.52M).
  • Biodesix is more profitable, keeping -39.8 cents of every revenue dollar as net income versus -9551.9 cents for Aclarion.
  • Aclarion grew revenue faster in its latest fiscal year (+65.62% vs +24.08%).

About Aclarion

ACON stock →

Aclarion, Inc. operates as a healthcare technology company in the United States.

Health Care · Medical Specialities · 10 employees

About Biodesix

BDSX stock →

Biodesix, Inc. operates as a diagnostic solutions company.

Health Care · Medical Specialities · 334 employees

ACON vs BDSX FAQ

Which is bigger, Aclarion or Biodesix?

Biodesix (BDSX) is larger, with a market capitalization of $83.83M compared with $3.52M for Aclarion (ACON).

Are Aclarion and Biodesix in the same industry?

Yes. Both are classified in the Medical Specialities industry within the Health Care sector.

More comparisons